Boston Scientific Corporation (BSX) is an interesting player in the Healthcare space, with a focus on Medical Appliances & Equipment. The stock has been active on the tape, currently trading at $31.95, up from yesterday’s close by 2.96%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.Fundamental Analysis
Boston Scientific Corporation (BSX) currently trades with a market capitalization of $43.98 Billion. That value represents a market adjusting for revenues that have been growing by 10.14 % on a quarterly year/year basis as of the company’s last quarterly report.
You can get a sense of how sustainable that is by a levered free cash flow of $1.24 Billion over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of $0.34 on a per share basis this quarter. Perhaps, that suggests something about why 0.86% of the outstanding share supply is held by institutional investors.
It’s important to check the technicals to get a sense of how BSX has been acting. Looking at the stock’s movement on the chart, Boston Scientific Corporation recorded a 52-week high of $31.18. It is now trading -0.77% off that level. The stock is trading $29.40 its 50-day moving average by -2.55%. The stock carved out a 52-week low down at $24.54.
In recent action, Boston Scientific Corporation (BSX) has made a move of +5.52% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 14.04, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 1.21% with $1.38 Billion sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of BSX.